ICRES is an acronym for Integrated Chikungunya Research and is a collaborative project supported by the European Union under the Health Cooperation Work Programme of the 7th Framework programme (grant agreement number 261202).

This project will integrate the expertise of EU laboratories with a long and strong track record of research on alphaviruses with EU laboratories that started work on CHIKV following the outbreak in La Reunion and laboratories from SE Asia working on this virus. The project will generate new molecular and cellular tools for research and applied studies, and develop a vaccine which at the end of this project is ready to enter clinical trials.

It is a collaboration of The Pirbright Institute, UK; Steinbeis Innovation gGmbh, Germany; University of Malaya, Malaysia; Université de la Réunion, France; Biomedical Sciences Institutes Limited by Guarantee, Singapore; Helsingin Yliopisto, Finland; Commissariat à l'énergie Atomique et aux Énergies Alternatives, France; Tartu Ülikool, Estonia; L'Institut Pasteur, France; Karolinska Institutet, Sweden; Universitätsklinikum Bonn, Germany.